African Union Specialized Technical Committee on Health, Population and Drug Control

African Union Specialized Technical Committee on Health, Population and Drug Control
Name	African Union Specialized Technical Committee on Health, Population and Drug Control
Type	Specialized Technical Committee
Parent organization	African Union
Established	2002
Headquarters	Addis Ababa
Languages	Arabic, English, French, Portuguese, Spanish

Contents

African Union Specialized Technical Committee on Health, Population and Drug Control The Specialized Technical Committee on Health, Population and Drug Control is a policy advisory body of the African Union charged with coordinating continental responses to public health, population dynamics, and pharmaceuticals, working alongside institutions such as the African CDC, the World Health Organization, the United Nations Population Fund, and the World Bank. It synthesizes guidance from summits like the African Union Summit and aligns with instruments including the African Union Agenda 2063, the Maputo Protocol, and the Abuja Declaration to advise heads of state and ministers across African Union member states and regional blocs such as the Economic Community of West African States and the Southern African Development Community.

Mandate and Objectives

The committee’s mandate is derived from decisions of the Assembly of the African Union and the Council of the African Union to promote continental health security, reproductive health, and pharmaceutical regulation through normative guidance, technical cooperation, and monitoring of commitments such as the Abuja Declaration and the African Continental Free Trade Area where health dimensions intersect. Core objectives include strengthening capacities of national ministries like the Ministry of Health (Nigeria) and the Ministry of Health (Kenya), supporting implementation of frameworks such as the International Health Regulations (2005) and the Global Action Plan on Antimicrobial Resistance, and coordinating with agencies like the Joint United Nations Programme on HIV/AIDS and the Global Fund to Fight AIDS, Tuberculosis and Malaria to translate policy into resources and programs.

The committee has overseen initiatives including continental strategies on HIV/AIDS, malaria, tuberculosis, and non-communicable diseases informed by partnerships with UNAIDS, Roll Back Malaria Partnership, and the Stop TB Partnership. It promotes pharmaceutical policy through harmonization efforts connected to the African Medicines Agency and regional regulatory networks like the East African Community Medicines Regulatory Harmonization and supports vaccine access mechanisms similar to Gavi, the Vaccine Alliance. Programs addressing population dynamics draw from collaborations with the United Nations Population Fund and research institutions such as the African Population and Health Research Center. Emergency preparedness activities coordinate with the Global Health Security Agenda and the World Health Organization during outbreaks like the Ebola virus epidemic in West Africa and the COVID-19 pandemic.

Policy outputs are developed through technical working groups that include representatives from national ministries, the African CDC, the World Health Organization, the United Nations Children's Fund, and civil society actors like Médecins Sans Frontières and the International Planned Parenthood Federation. The committee forges partnerships with multilateral funders such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and bilateral agencies including the United States Agency for International Development and Department for International Development while engaging research partners like London School of Hygiene & Tropical Medicine and Harvard T.H. Chan School of Public Health for evidence synthesis and capacity building. It contributes to continental normative frameworks such as the Pharmaceutical Manufacturing Plan for Africa and aligns with international treaties like the International Health Regulations (2005).

Plenary meetings convene periodically in Addis Ababa or at AU summits, bringing together ministers from Member States of the African Union, technical experts from the African CDC, and representatives from partners including the World Health Organization and United Nations Economic Commission for Africa. Decisions follow procedures established by the African Union Commission and are adopted by consensus or by vote at sessions reported to the Council of the African Union and the Assembly of the African Union, with implementation monitored through reporting mechanisms linked to the African Peer Review Mechanism and sectoral scorecards.

The committee has faced challenges related to financing, coordination, and implementation, especially given competing priorities among Member States of the African Union and reliance on external funding from entities like the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Bill & Melinda Gates Foundation, and bilateral donors. Critics from advocacy groups and academics at institutions such as the University of Cape Town and Makerere University have highlighted gaps in accountability, slow progress on regulatory harmonization around the African Medicines Agency, and limited inclusion of community organizations like Community Health Workers networks. Additional critiques reference tensions between continental policymaking and national sovereignty exemplified in debates during African Union Summit sessions and interactions with partners such as the World Health Organization and the United Nations.